Complications of therapy and a diagnostic dilemma case of - CASE 2. Cutaneous toxicity induced by cetuximab

被引:21
作者
Monti, M [1 ]
Mancini, LL
Ferrari, B
Rahal, D
Santoro, A
机构
[1] Ist Clin Humanitas Rozzano, Dept Dermatol, Milan, Italy
[2] Ist Clin Humanitas Rozzano, Dept Oncol, Milan, Italy
[3] Ist Clin Humanitas Rozzano, Div Pathol, Milan, Italy
关键词
D O I
10.1200/JCO.2003.04.169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4651 / 4653
页数:3
相关论文
共 8 条
[1]   Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition [J].
Albanell, J ;
Rojo, F ;
Averbuch, S ;
Feyereislova, A ;
Mascaro, JM ;
Herbst, R ;
LoRusso, P ;
Rischin, D ;
Sauleda, S ;
Gee, J ;
Nicholson, RI ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :110-124
[2]  
Baselga J, 2001, EUR J CANCER, V37, pS16
[3]   Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody [J].
Boucher, KW ;
Davidson, K ;
Mirakhur, B ;
Goldberg, J ;
Heymann, WR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) :632-633
[4]  
Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO
[5]  
2-C
[6]  
Jost M, 2000, EUR J DERMATOL, V10, P505
[7]   Epidermal growth factor receptor biology (IMC-C225) [J].
Kim, ES ;
Khuri, FR ;
Herbst, RS .
CURRENT OPINION IN ONCOLOGY, 2001, 13 (06) :506-513
[8]   Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors [J].
Kimyai-Asadi, A ;
Jih, MH .
ARCHIVES OF DERMATOLOGY, 2002, 138 (01) :129-131